An injectable, in situ forming type II collagen/hyaluronic acid hydrogel vehicle for chondrocyte delivery in cartilage tissue engineering

Drug Delivery and Translational Research

Volumn 4, Issue 2, 2014, Pages 149-158

  Kontturi, Leena Stiina ^a   Järvinen, Elina ^a   Muhonen, Virpi ^a   Collin, Estelle C ^b   Pandit, Abhay S ^b   Kiviranta, Ilkka ^a,c   Yliperttula, Marjo ^a   Urtti, Arto ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Cartilage tissue engineering; Chondrocyte; Hyaluronic acid; Injectable hydrogel; Type II collagen

Indexed keywords

AGGRECAN; BIOMATERIAL; COLLAGEN TYPE 2; GLYCOSAMINOGLYCAN POLYSULFATE; HYALURONIC ACID; MACROGOL; POLYETHYLENEGLYCOL ETHER 4 SUCCINIMIDYL GLUTARATE; TETRASUCCINIMIDYL GLUTARATE; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ARTICLE; CARTILAGE; CARTILAGE CELL; CELL CULTURE; CELL ENCAPSULATION; CELL PROLIFERATION; CELL STRUCTURE; CELL THERAPY; CELL VIABILITY; EXTRACELLULAR MATRIX; GENE EXPRESSION; HYDROGEL; IN VITRO STUDY; INJECTABLE IMPLANT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; TISSUE ENGINEERING;

EID: 84897453289     PISSN: 2190393X     EISSN: 21903948     Source Type: Journal    
DOI: 10.1007/s13346-013-0188-1     Document Type: Article

References (42)

1. Poole AR, Kojima T, Yasuda T, Mwale F, Kobayashi M, Laverty S. Composition and structure of articular cartilage: a template for tissue repair. Clin Orthop Relat Res. 2001;391: S26-33.
2. Chung C, Burdick JA. Engineering cartilage tissue. Adv Drug Deliv Rev. 2008;60(2): 243-62.
3. Mollenhauer JA. Perspectives on articular cartilage biology and osteoarthritis. Injury. 2008;39: S5-12.
4. Brittberg M, Lindahl A, Nilsson A, Ohlsson C, Isaksson O, Peterson L. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med. 1994;331(14): 889-95.
5. Brittberg M. Autologous chondrocyte implantation-technique and long-term follow-up. Injury. 2008;39: S40-9.
6. Melero-Martin JM, Al-Rubeai M (2007) In Vitro Expansion of Chondrocytes. In: Ashammakhi N, Reis R, Chiellini E, editors. Topics in Tissue Engineering. 2007;chapter 1, pp. 1-37.
7. Gaissmaier C, Koh JL, Weise K. Growth and differentiation factors for cartilage healing and repair. Injury. 2008;39: S88-96.
8. Lu L, Valenzuela RG, Yaszemski MJ. Articular cartilage tissue engineering. e-biomed. J Regen Med. 2000;1: 99-114. doi: 10. 1089/152489000420113.
9. Vinatier C, Bouffi C, Merceron C, Gordeladze J, Brondello JM, Jorgensen C, et al. Cartilage tissue engineering: towards a biomaterial-assisted mesenchymal stem cell therapy. Curr Stem Cell Res Ther. 2009;4(4): 318-29.
10. Frenkel SR, Di Cesare PE. Scaffolds for articular cartilage repair. Ann Biomed Eng. 2004;32(1): 26-34.
11. Kim IL, Mauck RL, Burdick JA. Hydrogel design for cartilage tissue engineering: a case study with hyaluronic acid. Biomaterials. 2011;32(34): 8771-82.
12. Lum L, Elisseeff J. Injectable Hydrogels for Cartilage Tissue Engineering. In: Ashammakhi N, Ferretti P, editors. Topics in Tissue Engineering. 2003;chapter 4, pp. 1-25.
13. Amini AA. Nair LS (2012) Injectable hydrogels for bone and cartilage repair. Biomed Mater. 2012;7(2): 024105.
14. Spiller KL, Maher SA, Lowman AM. Hydrogels for the repair of articular cartilage defects. Tissue Eng Part B Rev. 2011;17(4): 281-99.
15. Taguchi T, Xu L, Kobayashi H, Taniguchi A, Kataoka K, Tanaka J. Encapsulation of chondrocytes in injectable alkali-treated collagen gels prepared using poly(ethylene glycol)-based 4-armed star polymer. Biomaterials. 2005;26(11): 1247-52.
16. Collin EC, Grad S, Zeugolis DI, Vinatier CS, Clouet JR, Guicheux JJ, et al. An injectable vehicle for nucleus pulposus cell-based therapy. Biomaterials. 2011;32(11): 2862-70.
17. Grimau E, Heymann D, Redini F. Recent advances in TGF-β effects on chondrocyte metabolism. Potential therapeutic roles of TGF-β in cartilage disorders. Cytokine Growth Factor Rev. 2002;13(3): 241-57.
18. Blaney Davidson EN, van der Kraan PM, van den Berg WB. TGF-β and osteoarthritis. Osteoarthr Cartil. 2007;15(6): 597-604.
19. Pulkkinen HJ, Tiitu V, Valonen P, Hamalainen ER, Lammi MJ, Kiviranta I. Recombinant human type II collagen as a material for cartilage tissue engineering. Int J Artif Organs. 2008;31(11): 960-9.
20. Nehrer S, Breinan HA, Ramappa A, Young G, Shortkroff S, Louie LK, et al. Matrix collagen type and pore size influence behaviour of seeded canine chondrocytes. Biomaterials. 1997;18(11): 769-76.
21. Nehrer S, Breinan HA, Ramappa A, Shortkroff S, Young G, Minas T, et al. Canine chondrocytes seeded in type I and type II collagen implants investigated in vitro. J Biomed Mater Res. 1997;38(2): 95-104.
22. Nehrer S, Breinan HA, Ramappa A, Hsu HP, Minas T, Shortkroff S, et al. Chondrocyte-seeded collagen matrices implanted in a chondral defect in a canine model. Biomaterials. 1998;19(24): 2313-28.
23. Veilleux NH, Yannan IV, Spector M. Effect of passage number and collagen type on the proliferative, biosynthetic, and contractile activity of adult canine articular chondrocytes in type I and II collagen-glycosaminoglycan matrices in vitro. Tissue Eng. 2004;10(1-2): 119-27.
24. Bosnakovski D, Mizuno M, Kim G, Takagi S, Okumura M, Fujinaga T. Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells (MSCs) in different hydrogels: influence of collagen type II extracellular matrix on MSC chondrogenesis. Biotechnol Bioeng. 2006;93(6): 1152-63.
25. Lu Z, Doulabi BZ, Huang C, Bank RA, Helder MN. Collagen type II enhances chondrogenesis in adipose tissue-derived stem cells by affecting cell shape. Tissue Eng Part A. 2010;16(1): 81-90.
26. Chang CH, Lin FH, Kuo TF, Liu HC. Cartilage tissue engineering. Biomed Eng Appl Basis Comm. 2005;17(2): 61-71.
27. Akmal M, Singh A, Anand A, Kesani A, Aslam N, Goodship A, et al. The effects of hyaluronic acid on articular chondrocytes. J Bone Joint Surg Br. 2005;87(8): 1143-9.
28. Orban JM, Wilson LB, Kofroth JA, El-Kurdi MS, Maul TM, Vorp DA. Crosslinking of collagen gels by transglutaminase. J Biomed Mater Res A. 2004;68(4): 756-62.
29. O'Halloran D, Collighan RJ, Griffin M, Pandit AS. Characterization of a microbial transglutaminase cross-linked type II collagen scaffold. Tissue Eng. 2006;12(6): 1467-74.
30. Ibusuki S, Halbesma GJ, Randolph MA, Redmond RW, Kochevar IE, Gill TJ. Photochemically cross-linked collagen gels as three-dimensional scaffolds for tissue engineering. Tissue Eng. 2007;13(8): 1995-2001.
31. Lee CR, Breinan HA, Nehrer S, Spector M. Articular cartilage chondrocytes in type I and type II collagen-GAG matrices exhibit contractile behavior in vitro. Tissue Eng. 2000;6(5): 555-65.
32. Lee CR, Grodzinsky AJ, Spector M. The effects of cross-linking of collagen-glycosaminoglycan scaffolds on compressive stiffness, chondrocyte-mediated contraction, proliferation and biosynthesis. Biomaterials. 2001;22(23): 3145-54.
33. Subramanian A, Lin HY. Crosslinked chitosan: its physical properties and the effects of matrix stiffness on chondrocyte cell morphology and proliferation. J Biomed Mater Res A. 2005;75(3): 742-53.
34. Park H, Temenoff JS, Holland TA, Tabata Y, Mikos AG. Delivery of TGF-β1 and chondrocytes via injectable, biodegradable hydrogels for cartilage tissue engineering applications. Biomaterials. 2005;26(34): 7095-103.
35. Xiaohong H, Ma L, Wang C, Gao C. Gelatin hydrogel prepared by photo-initiated polymerization and loaded with TGF-β1 for cartilage tissue engineering. Macromol Biosci. 2009;9(12): 1194-201.
36. Faikrua A, Wittaya-Areekul S, Oonkhanond B, Viyoch J. In vivo chondrocyte and transforming growth factor-β1 delivery using the thermosensitive chitosan/starch/β-glycerol phosphate hydrogel. J Biomater Appl. 2012;28: In press.
37. Qi WN, Scully SP. Extracellular collagen modulates the regulation of chondrocytes by transforming growth factor-β1. J Orthop Res. 1997;15(4): 483-90.
38. Qi WN, Scully SP. Effect of type II collagen in chondrocyte response to TGF-β1 regulation. Exp Cell Res. 1998;241(1): 142-50.
39. Galois L, Hutasse S, Cortial D, Rousseau CF, Grossin L, Ronziere MC, et al. Bovine chondrocyte behaviour in three-dimensional type I collagen gel in terms of gel contraction, proliferation and gene expression. Biomaterials. 2006;27(1): 79-90.
40. Chung C, Erickson IE, Mauck RL, Burdick JA. Differential behavior of auricular and articular chondrocytes in hyaluronic acid hydrogels. Tissue Eng Part A. 2008;14(7): 1121-31.
41. Freyria AM, Ronzière MC, Cortial D, Galois L, Hartmann D, Herbage D, et al. Comparative phenotypic analysis of articular chondrocytes cultured within type I or type II collagen scaffolds. Tissue Eng Part A. 2009;15(6): 1233-45.
42. Khan IM, Francis L, Theobald PS, Perni S, Young RD, Prokopovich P, et al. In vitro growth factor-induced bio engineering of mature articular cartilage. Biomaterials. 2013;34(5): 1478-87.